<?xml version="1.0"?><rdf:RDF xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:edm="http://www.europeana.eu/schemas/edm/" xmlns:wgs84_pos="http://www.w3.org/2003/01/geo/wgs84_pos" xmlns:foaf="http://xmlns.com/foaf/0.1/" xmlns:rdaGr2="http://rdvocab.info/ElementsGr2" xmlns:oai="http://www.openarchives.org/OAI/2.0/" xmlns:owl="http://www.w3.org/2002/07/owl#" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:ore="http://www.openarchives.org/ore/terms/" xmlns:skos="http://www.w3.org/2004/02/skos/core#" xmlns:dcterms="http://purl.org/dc/terms/"><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-YOVR04L8/5ba28d30-970e-4974-b2c6-2f04e0fd0064/HTML"><dcterms:extent>20 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-YOVR04L8/54585437-02f5-44a7-be26-6af64d373746/PDF"><dcterms:extent>183 KB</dcterms:extent></edm:WebResource><edm:WebResource rdf:about="http://www.dlib.si/stream/URN:NBN:SI:doc-YOVR04L8/fd09be90-c6a2-4276-897f-14241f46e360/TEXT"><dcterms:extent>11 KB</dcterms:extent></edm:WebResource><edm:TimeSpan rdf:about="1992-2025"><edm:begin xml:lang="en">1992</edm:begin><edm:end xml:lang="en">2025</edm:end></edm:TimeSpan><edm:ProvidedCHO rdf:about="URN:NBN:SI:doc-YOVR04L8"><dcterms:isPartOf rdf:resource="https://www.dlib.si/details/URN:NBN:SI:spr-FNIFVE9S" /><dcterms:issued>2001</dcterms:issued><dc:creator>Baichev, George</dc:creator><dc:creator>Gorchev, Grigor</dc:creator><dc:creator>Sergieva, Sonia</dc:creator><dc:format xml:lang="sl">številka:1</dc:format><dc:format xml:lang="sl">letnik:35</dc:format><dc:format xml:lang="sl">4 strani</dc:format><dc:format xml:lang="sl">str. 43-46</dc:format><dc:identifier>COBISSID:12888025</dc:identifier><dc:identifier>ISSN:1318-2099</dc:identifier><dc:identifier>URN:URN:NBN:SI:doc-YOVR04L8</dc:identifier><dc:language>en</dc:language><dc:publisher xml:lang="sl">Association of Radiology and Oncology</dc:publisher><dcterms:isPartOf xml:lang="sl">Radiology and oncology (Ljubljana)</dcterms:isPartOf><dc:subject xml:lang="en">Axilla</dc:subject><dc:subject xml:lang="en">Biopsy</dc:subject><dc:subject xml:lang="en">breast</dc:subject><dc:subject xml:lang="en">Breast neoplasms</dc:subject><dc:subject xml:lang="en">diagnostika</dc:subject><dc:subject xml:lang="sl">dojke</dc:subject><dc:subject xml:lang="en">Lymph nodes</dc:subject><dc:subject xml:lang="en">Lymphatic metastasis</dc:subject><dc:subject xml:lang="en">Neoplasm staging</dc:subject><dc:subject xml:lang="en">Pathology</dc:subject><dc:subject xml:lang="sl">rak (medicina)</dc:subject><dcterms:temporal rdf:resource="1992-2025" /><dc:title xml:lang="sl">Sentinel lymph nodes identification in early breast cancer - peritumoral or subareolar injection of lymphotropic blue dye?| Ali naj pri ugotavljanju varovalnih bezgavk pri bolnicah z zgodnjim rakom dojke uporabljamo peritumorsko ali subareolno iniciranje limfotropnega modrila?|</dc:title><dc:description xml:lang="sl">Background. The sentinel lymph node (SLN) biopsy is a recently developed, minimally invasive method for staging the axilla in patients with early breastcancer. The authors investigated the optimal technique-peritumoral versus subareolar injection for the localization of the SLN. Patients and methods. 192 procedures out of 238 ones were performed using a blue dye peritumoral injection at the early breast cancer site against 46, with a subareolar technique. All patients underwent sentine node biopsy, followed by an axillary node dissection. Results. The SLN were metastatic in 69 out of 80 axillary positive patients that accounted for 86,3%. The sentinel node histology correctly predicted the axillary disease in 90,6% with a peritumoralinjection versus 68,8% with a subareolar lymphatic mapping. Conclusions. This experience indicates that the peritumoral injection of blue dye is a more accurate than the subareolar one for axillary staging</dc:description><dc:description xml:lang="sl">Biopsija varovalnih bezgavk, ki so jo razvili v novejšem času, je minimalna invazivna metoda, s katero lahko ugotovimo prizadetost aksilarnih bezgavk pri bolnicah z zgodnejšo obliko raka dojke. Da bi ugotovili optimalno tehniko za lokalizacijo varovalnih bezgavk, so avtorji primerjali peritumorsko in subareolarno injiciranje modrila. Bolniki in metode. Pri 192 od 238 bolnicah, ki so imele zgodnejšo obliko raka dojke, so uporabili peritumorsko iniciranje modrila, pri 46 pa subaereolarno iniciranje. Pri vseh je bila nato narejena biopsija varovalne bezgavke po predhodni kirurški odstranitvi aksilarnih bezgavk. Rezultati. 80 bolnic je imelo metastatsko spremenjene aksilarne bezgavke, 69 bolnic pa je imelo metastatsko prizadete varovalne bezgavke, kar predstavlja 86,3%. Patohistološki pregled varovalne bezgavke je pravilno ocenil prizadetost aksilarnih bezgavk v 90,6%, če je bilo barvilo inicirano peritumorsko, če je bilo inicirano subareolarno, pa le v 68,8%. Zaključki. Izkušnje avtorjev kažejo, da je za ocenitev prizadetosti aksilarnih bezgavk primernejša peritumorska aplikacija modrila kot pa subareolarna</dc:description><edm:type>TEXT</edm:type><dc:type xml:lang="sl">znanstveno časopisje</dc:type><dc:type xml:lang="en">journals</dc:type><dc:type rdf:resource="http://www.wikidata.org/entity/Q361785" /></edm:ProvidedCHO><ore:Aggregation rdf:about="http://www.dlib.si/?URN=URN:NBN:SI:doc-YOVR04L8"><edm:aggregatedCHO rdf:resource="URN:NBN:SI:doc-YOVR04L8" /><edm:isShownBy rdf:resource="http://www.dlib.si/stream/URN:NBN:SI:doc-YOVR04L8/54585437-02f5-44a7-be26-6af64d373746/PDF" /><edm:rights rdf:resource="http://creativecommons.org/licenses/by/4.0/" /><edm:provider>Slovenian National E-content Aggregator</edm:provider><edm:intermediateProvider xml:lang="en">National and University Library of Slovenia</edm:intermediateProvider><edm:dataProvider xml:lang="sl">Društvo radiologije in onkologije</edm:dataProvider><edm:object rdf:resource="http://www.dlib.si/streamdb/URN:NBN:SI:doc-YOVR04L8/maxi/edm" /><edm:isShownAt rdf:resource="http://www.dlib.si/details/URN:NBN:SI:doc-YOVR04L8" /></ore:Aggregation></rdf:RDF>